J Biol Chem 1995, 270:15926–15929 PubMedCrossRef 17 Burns K, Dug

J Biol Chem 1995, 270:15926–15929.PubMedCrossRef 17. Burns K, Duggan B, Atkinson EA, Famulski KS, Nemer M, Bleackley RC, Michalak M: Modulation of gene expression by calreticulin binding to the glucocorticoid receptor. Nature 1994, 367:476–480.PubMedCrossRef 18. Zapun A, Darby NJ, Tessier DC, Michalak M, Bergeron JJ, Thomas DY: Enhanced catalysis

of ribonuclease B folding by the interaction of calnexin or calreticulin with ERp57. J Biol Chem 1998, 273:6009–6012.PubMedCrossRef 19. Peterson JR, Ora A, Van PN, Helenius A: Transient, lectin-like association of calreticulin with folding intermediates of cellular and viral glycoproteins. Mol Biol Cell 1995, 6:1173–1184.PubMed BAY 63-2521 molecular weight 20. Gelebart P, Opas M, Michalak M: Calreticulin, a Ca2 + -binding chaperone of the endoplasmic reticulum. Int J Biochem Cell Biol 2005, 37:260–66.PubMedCrossRef 21. Liu B, Ye D, Song X, Zhao X, Yi L, Song J, Zhang Z, Zhao Q: A novel fusion protein vaccine by two different families of heat shock proteinslinked with HPV16 E7 generates potent antitumor immunity and antiangiogenesis. Vaccine 2008, 26:1387–96.PubMedCrossRef 22. Cheng WF, Lee CN, Su YN, Chai CY, Chang MC, Polo JM, Hung CF,

Wu TC, Hsieh CY, Chen CA: Sindbis virus Adavosertib replicon particles encoding calreticulin linked to a tumor antigen generate long-term tumor-specific immunity. Cancer gene ther 2006, 13:873–85.PubMedCrossRef 23. Alur M, Nguyen MM, Eggener SE: Suppressive Roles of Calreticulin in Prostate Cancer Growth and Metastasis. Am J Pathol 2009, 175:882–90.PubMedCrossRef 24. Grossman SA, Batara JF: Current management of glioblastoma multiforme. Semin Oncol 2004, 31:635–44.PubMedCrossRef 25. Chambers AF, Shoji M, Abe K: Dissemination and growth of cancer cells in metastatic sites. Nature Vactosertib concentration Reviews Cancer 2002, 2:563–572.PubMedCrossRef 26. Duffy MJ, McGowan PM, Gallagher WM: Cancer invasion and metastasis: changing views. J Pathol 2008, 214:283–293.PubMedCrossRef 27. Deryugina EI, Quigley JP: Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006, 25:9–34.PubMedCrossRef 28. Okunaga T, Urata Y, Goto S, Matsuo

T: Calreticulin, a molecular chaperone in the endoplasmic reticulum, modulates radiosensitivity Selleckchem Staurosporine of human glioblastoma U251MG cells. Cancer Res 2006, 66:8662–71.PubMedCrossRef 29. Chen NH, Liu JW, Zhong JJ: Ganoderic acid Me inhibits tumor invasion through down-regulating matrix metalloproteinases 2/9 gene expression. J Biol Chem 2008, 108:212–6. 30. Cook-Mills JM: Hydrogen peroxide activation of endothelial cell-associated MMPs during VCAM-1-dependent leukocyte migration. Cell Mol Biol (Noisy-le-grand) 2006, 52:8–16. 31. Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86:353–64.PubMedCrossRef 32. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1:27–31.PubMedCrossRef 33.

Comments are closed.